What after Leeann Havner’s Insider Acquisition of General Finance (GFN) Stock?; Quest Diagnostics (DGX) Had 11 Bulls

Quest Diagnostics Incorporated (NYSE:DGX) Logo

Quest Diagnostics Incorporated (NYSE:DGX) Ratings Coverage

Among 21 analysts covering Quest Diagnostics (NYSE:DGX), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Quest Diagnostics had 73 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was upgraded by Argus Research on Wednesday, March 7 to “Buy”. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Outperform” rating given on Friday, May 25 by Credit Suisse. The rating was upgraded by Bank of America on Thursday, March 16 to “Neutral”. The stock of Quest Diagnostics Incorporated (NYSE:DGX) earned “Sector Perform” rating by RBC Capital Markets on Friday, January 29. The rating was maintained by RBC Capital Markets with “Sector Perform” on Friday, October 23. Piper Jaffray maintained Quest Diagnostics Incorporated (NYSE:DGX) rating on Wednesday, October 11. Piper Jaffray has “Hold” rating and $107.0 target. Mizuho maintained it with “Buy” rating and $103.0 target in Thursday, October 19 report. Jefferies maintained the shares of DGX in report on Friday, November 24 with “Hold” rating. The rating was maintained by Canaccord Genuity on Monday, September 11 with “Buy”. Credit Suisse initiated Quest Diagnostics Incorporated (NYSE:DGX) on Friday, February 2 with “Hold” rating. See Quest Diagnostics Incorporated (NYSE:DGX) latest ratings:

29/05/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Overweight Upgrade
25/05/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $118 New Target: $121 Maintain
25/05/2018 Broker: Mizuho Rating: Buy Maintain
01/05/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Outperform New Target: $115 Reinitiate
19/03/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $113 New Target: $115 Maintain
14/03/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Equal-Weight Old Target: $92 Upgrade
07/03/2018 Broker: Argus Research Old Rating: Hold New Rating: Buy Old Target: $102 Upgrade
13/02/2018 Broker: Credit Suisse Rating: Buy New Target: $118.0 Upgrade
02/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $113.0 Maintain
02/02/2018 Broker: Credit Suisse Rating: Hold New Target: $107.0 Initiate

Since January 2, 2018, it had 0 insider purchases, and 16 sales for $55.61 million activity. 494 shares were sold by Davis J. E., worth $50,754 on Friday, February 23. RUSCKOWSKI STEPHEN H had sold 168,490 shares worth $18.03 million on Friday, May 25. Klug Robert A sold $119,932 worth of stock. 1,423 shares valued at $148,576 were sold by PREVOZNIK MICHAEL E on Tuesday, February 27. GUINAN MARK sold 61,533 shares worth $6.50M. The insider Doherty Catherine T. sold 1,820 shares worth $189,971. 1,644 Quest Diagnostics Incorporated (NYSE:DGX) shares with value of $173,623 were sold by LEIDEN JEFFREY M.

More recent Quest Diagnostics Incorporated (NYSE:DGX) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on May 29, 2018. Also Seekingalpha.com published the news titled: “UnitedHealth, Quest Diagnostics unveil strategic partnership” on May 24, 2018. Bizjournals.com‘s news article titled: “LabCorp CEO brings in $4.5 million from exercising, selling stock” with publication date: May 29, 2018 was also an interesting one.

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company has market cap of $14.66 billion. The companyÂ’s Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. It has a 19.23 P/E ratio. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices.

The stock increased 1.33% or $1.42 during the last trading session, reaching $107.95. About 675,727 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has declined 2.15% since June 3, 2017 and is downtrending. It has underperformed by 14.72% the S&P500.

Investors sentiment decreased to 0.8 in 2018 Q1. Its down 0.12, from 0.92 in 2017Q4. It turned negative, as 35 investors sold Quest Diagnostics Incorporated shares while 217 reduced holdings. 71 funds opened positions while 131 raised stakes. 111.81 million shares or 3.17% less from 115.48 million shares in 2017Q4 were reported. Cibc World has 0.03% invested in Quest Diagnostics Incorporated (NYSE:DGX). 738,000 were reported by Lsv Asset Management. Baker Ellis Asset Mgmt Ltd Co reported 0.04% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Price T Rowe Assoc Md has 0% invested in Quest Diagnostics Incorporated (NYSE:DGX). Howe And Rusling Inc invested in 0% or 30 shares. Sg Americas has invested 0.05% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Moreover, Millennium Management Limited Liability has 0.02% invested in Quest Diagnostics Incorporated (NYSE:DGX) for 124,357 shares. Cornercap Invest Counsel invested 0.54% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Envestnet Asset Mgmt has invested 0% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Kentucky Retirement System Ins Fund owns 0.06% invested in Quest Diagnostics Incorporated (NYSE:DGX) for 3,105 shares. Grantham Mayo Van Otterloo And Ltd Limited Liability Company has invested 0% in Quest Diagnostics Incorporated (NYSE:DGX). 3,211 were reported by Invest House Lc. Exxonmobil Inv Mngmt Tx accumulated 20,765 shares or 0.06% of the stock. Hm Payson owns 10,505 shares. State Of New Jersey Common Pension Fund D, a New Jersey-based fund reported 15,000 shares.

More news for General Finance Corporation (NASDAQ:GFN) were recently published by: Seekingalpha.com, which released: “General Finance Corp.: Cyclical Upside Has Been Realized” on June 01, 2018. Seekingalpha.com‘s article titled: “General Finance’s (GFN) CEO Jody Miller on Q3 2018 Results – Earnings Call Transcript” and published on May 09, 2018 is yet another important article.

Analysts await General Finance Corporation (NASDAQ:GFN) to report earnings on September, 5. They expect $-0.03 EPS, up 57.14% or $0.04 from last year’s $-0.07 per share. After $-0.06 actual EPS reported by General Finance Corporation for the previous quarter, Wall Street now forecasts -50.00% EPS growth.

Investors sentiment increased to 2 in 2018 Q1. Its up 0.43, from 1.57 in 2017Q4. It improved, as 2 investors sold General Finance Corporation shares while 7 reduced holdings. 11 funds opened positions while 7 raised stakes. 5.69 million shares or 6.41% more from 5.35 million shares in 2017Q4 were reported. Millennium Mngmt Lc holds 0% or 150,161 shares. Goldman Sachs Group Inc invested 0% of its portfolio in General Finance Corporation (NASDAQ:GFN). Litman Gregory Asset Mngmt Ltd Liability Com owns 34,827 shares. Northern Trust accumulated 15,156 shares. Tower Capital Limited Liability Com (Trc) accumulated 219 shares. Blackrock Inc reported 0% in General Finance Corporation (NASDAQ:GFN). Bridgeway owns 331,121 shares for 0.03% of their portfolio. Wells Fargo & Mn holds 0% or 7,565 shares in its portfolio. Credit Suisse Ag invested in 13,562 shares. Geode Capital Management Limited Liability Corp stated it has 0% of its portfolio in General Finance Corporation (NASDAQ:GFN). M&T Bank & Trust accumulated 25,000 shares. Bank Of America De has invested 0% in General Finance Corporation (NASDAQ:GFN). Barclays Public Limited Com stated it has 0% in General Finance Corporation (NASDAQ:GFN). Vanguard Group Inc holds 372,545 shares or 0% of its portfolio. 81,985 were accumulated by Deutsche State Bank Ag.

Among 3 analysts covering General Finance Corporation (NASDAQ:GFN), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. General Finance Corporation has $1300 highest and $6 lowest target. $11.10’s average target is 0.00% above currents $11.1 stock price. General Finance Corporation had 5 analyst reports since September 9, 2015 according to SRatingsIntel. The firm has “Perform” rating given on Monday, September 21 by Oppenheimer. Singular Research initiated General Finance Corporation (NASDAQ:GFN) on Tuesday, February 21 with “Buy” rating.

Based on an average price per share of $11.0, Leeann Havner, the General Finance Corp’s shareholder invested in 1,321 shares of General Finance Corp worth precisely $14,531 U.S. Dollars . Leeann is trying to silently increase her company’s share, same as she did in the last month. She acquired another 295,000 shares worth $3.25 million USD. Currently, Mr. Leeann, possess 2.89 million shares, which accounts for 10.80% of the Company’s market capitalization.

The stock increased 3.26% or $0.35 during the last trading session, reaching $11.1. About 52,815 shares traded. General Finance Corporation (NASDAQ:GFN) has risen 124.00% since June 3, 2017 and is uptrending. It has outperformed by 111.43% the S&P500.

Quest Diagnostics Incorporated (NYSE:DGX) Institutional Positions Chart